Aposense Ltd.

Industry · 4 registered clinical trials.

Status	Trial	Phase	Started
Unknown	An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiati Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms	Phase 2	2010-12-01
Unknown	Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Resp Brain Metastases, Solid Tumors	Phase 2	2008-11-01
Terminated	18F ML-10 for Early Detection of Response of Brain Metastases to SRS Metastasis to Brain of Unknown Primary	Phase 2	2008-07-01
Completed	18F ML-10 for Early Detection of Response of Brain Metastases to WBRT Solid Tumors, Brain Metastases	Phase 2	2008-03-01